Aurantoside B

Molecular Formula: C₃₅H₄₄Cl₂N₂O₁₅

InChI: InChI=1/C35H44Cl2N2O15/c1-16(36)12-18(37)10-8-6-4-3-5-7-9-11-20(40)24-26(44)19(13-23(38)42)39(32(24)49)33-31(27(45)21(41)14-50-33)54-34-30(48)28(46)22(15-51-34)53-35-29(47)25(43)17(2)52-35/h3-12,17,19,21-22,25,27-31,33-35,41,43,45-49H,13-15H2,1-2H3,(H2,38,42)/b4-3+,7-5+,8-6+,11-9+,16-12+,18-10-/t17-,19+,21-,22-,25-,27-,28+,29+,30+,31+,33?,34+,35+/m1/s1/f/h38H2

InChIKey: InChIKey=FOGGGQRQDXLSPR-GIKUGCALDC
SMILES: CC1C(C(C(O1)OC2COC(C(C2O)O)OC3C(C(COC3N4C(C(=O)C(=C4O)C(=O)C=CC=CC=CC=CC=C(C=C(C)Cl)Cl)CC(=O)N)O)O)O)O

Names:
    Aurantoside B
    137895-71-7
    2-Pyrrolidineacetamide, 1-(O-5-deoxy-beta-D-arabinofuranosyl-(1-4)-O-beta-D-arabiniopyranosyl-(1-2)-beta-D-xylopyranosyl)-4-((2E,4E,6E,8E,10E,12E)-11,13-dichloro-1-hydroxy-2,4,6,8,10,12-tetradecanhexaenylidene)-3,5-dioxo,(2S,4E)
    2-[(2S)-4-[(2E,4E,6E,8E,10Z,12E)-11,13-dichlorotetradeca-2,4,6,8,10,12-hexaenoyl]-1-[(3S,4R,5R)-3-[(2S,3S,4R,5R)-5-[(2R,3S,4S,5R)-3,4-dihydroxy-5-methyl-oxolan-2-yl]oxy-3,4-dihydroxy-oxan-2-yl]oxy-4,5-dihydroxy-oxan-2-yl]-5-hydroxy-3-oxo-2H-pyrrol-2-yl]acetamide

Registries:
    PubChem CID 6450990
    PubChem ID 10556854